ORLANDO, Fla., Oct. 24, 2011 /PRNewswire/ -- GeneLink
BioSciences, Inc. (OTC Bulletin Board: GNLK), a leading
consumer genomics biotech company, today announced that it ranked
number 33 on Technology Fast 500™, Deloitte's ranking of 500
of the fastest growing technology, media, telecommunications, life
sciences and clean technology companies in North America. GeneLink grew 4,363 percent
during the period 2006-2010.
GeneLink's chief executive officer, Dr. Bernard L. Kasten, Jr., credits the Company's
leading genetic science and its proprietary genetic assessments and
personalized health products for the Company's dramatic revenue
growth. Dr. Kasten said, "We are proud that Deloitte has recognized
our remarkable growth for the third consecutive year. We at
GeneLink have spent the current year developing and formalizing
additional marketing relationships, some of which have been
announced, and enhancing our scientific resources, manufacturing
capabilities and infrastructure, which we anticipate will enable us
to sustain this impressive rate of growth."
"GeneLink, like all 2011 Technology Fast 500™ companies,
has excelled in fostering innovation and channeling it into
spectacular growth – against the backdrop of one of the most
challenging economies in history," said Eric Openshaw, vice chairman and U.S.
technology, media and telecommunications leader. Deloitte L.P.
"Deloitte commends GeneLink for this remarkable
accomplishment."
"We are pleased to honor GeneLink as a 2011 Technology Fast 500
company," said Mark Jensen, managing
partner, technology and venture capital services, Deloitte &
Touch LLP. "As one of the fastest growing tech companies in
North America, GeneLink has
demonstrated excellence in technological innovation,
entrepreneurship and rapid growth."
GeneLink previously ranked number 92 as a Technology Fast
500™ award winner for 2008 and number 66 for 2009.
About Deloitte's 2011 Technology Fast 500™
Technology Fast 500, which was conducted by Deloitte &
Touche, LLP, a subsidiary of Deloitte LLP, provides a ranking of
the fastest growing technology, media, telecommunications, life
sciences and clean technology companies – both public and private –
in North America. Technology Fast
500 award winners are selected based on percentage fiscal year
revenue growth from 2006 to 2010.
In order to be eligible for Technology Fast 500 recognition,
companies must own proprietary intellectual property or technology
that is sold to customers in products that contribute to a majority
of the company's operating revenues. Companies must have base-year
operating revenues of at least $50,000
USD or CD, and current-year operating revenues of at least
$5 million USD or CD. Additionally,
companies must be in business for a minimum of five years, and be
headquartered within North
America.
About GeneLink BioSciences, Inc.:
GeneLink Biosciences, Inc. (www.genelinkbio.com) is a
17-year-old leading biosciences company specializing in consumer
genomics. GeneLink's patented technologies include proprietary DNA
test assessments linked to personalized health, beauty and wellness
applications and products. Its DNA assessments provide information
that enables the customization of nutritional and skincare products
designed and manufactured to fulfill each individual consumer's
wellness needs.
This release contains certain forward-looking statements within
the meaning of section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. With the
exception of historical information contained herein, the matters
discussed in the press release involve risk and uncertainties.
Actual results could differ materially from those expressed in any
forward-looking statement. GeneLink disclaims any intention or
obligation to revise any forward-looking statements, whether as a
result of new information, future developments or otherwise.
SOURCE GeneLink BioSciences, Inc.
